Cooke RW et al. confirmed a significant difference in VEGF −634 G→C genotypes in infants with treated ROP, suggesting excess VEGF production caused by genetic differences predisposed to ROP development (25). This evidence concerns the gene VEGFA and retinopathy of prematurity.